Book Excerpt from <em>You Bet Your Life</em>
Book Excerpt from You Bet Your Life
In his book’s Introduction, physician-scientist Paul A. Offit reviews the unusual constellation of circumstances around the development of COVID-19 vaccines.
Book Excerpt from You Bet Your Life
Book Excerpt from You Bet Your Life

In his book’s Introduction, physician-scientist Paul A. Offit reviews the unusual constellation of circumstances around the development of COVID-19 vaccines.

In his book’s Introduction, physician-scientist Paul A. Offit reviews the unusual constellation of circumstances around the development of COVID-19 vaccines.

hydroxychloroquine
Elisabeth Bik Faces Legal Action After Criticizing Studies
Elisabeth Bik Faces Legal Action After Criticizing Studies
Shawna Williams | May 28, 2021
A complaint lodged by researchers in France prompts two petitions supporting Bik’s whistleblowing work.
The Top Retractions of 2020
The Top Retractions of 2020
Retraction Watch | Dec 15, 2020
The Retraction Watch team takes a look at the most important publishing mistakes this year.
<em>The Lancet&nbsp;</em>Alters Editorial Practices After Surgisphere Scandal
The Lancet Alters Editorial Practices After Surgisphere Scandal
Catherine Offord | Sep 22, 2020
The changes, which affect the declarations authors have to sign and the peer-review process, have received a mixed response from the scientific community.
FDA Pulls Emergency Use Authorization for Antimalarial Drugs
FDA Pulls Emergency Use Authorization for Antimalarial Drugs
Amanda Heidt | Jun 16, 2020
Hydroxychloroquine and chloroquine, once thought to be promising COVID-19 treatments, come with serious heart risks.
Exclusive
Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere
Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere
Catherine Offord | May 30, 2020
Scientists have raised questions about the dataset published in The Lancet last week that triggered the suspension of clinical trials around the world—and about Surgisphere Corporation, the company behind the study.
WHO Halts Hydroxychloroquine Testing Over Safety Concerns
WHO Halts Hydroxychloroquine Testing Over Safety Concerns
Catherine Offord | May 27, 2020
A paper published in The Lancet reported that hospitalized COVID-19 patients taking the drug had a higher risk of death, although some researchers have raised questions about the data.
Journal Publisher Concerned over Hydroxychloroquine Study
Journal Publisher Concerned over Hydroxychloroquine Study
Kerry Grens | Apr 9, 2020
The report by Didier Raoult and colleagues that examined the use of the anti-malarial drug in a small number of COVID-19 patients receives criticism from the very society that published it.
Chloroquine for COVID-19: Cutting Through the Hype
Chloroquine for COVID-19: Cutting Through the Hype
Chris Baraniuk | Mar 20, 2020
President Donald Trump has touted the drug as a treatment but scientists still don’t know for sure that it is effective in patients. A number of clinical trials aim to find out.